Stock-Based Compensation

On February 28, 2018, our shareholders approved amendments to the Company’s amended and restated 2000 Stock Plan (the “Amended and Restated 2000 Stock Plan”). The Amended and Restated 2000 Stock Plan (i) increases the number of shares issuable by 82,250,000 to 83,500,000 shares; (ii) permit the Company’s Board of Directors (the “Board”) to make proportional adjustments to outstanding awards affected by a change in the Company’s capital structure, and in addition to or in lieu of such adjustments, to permit the Board to pay dividends, dividend equivalents, or similar rights in conjunction to any such changes in the Company’s capital structure; and (iii) certain updates to reflect changes in law relating to Section 162(m).

As of December 31, 2018, we had 9.4 million shares available for future grants under the Amended and Restated 2000 Stock Plan. We recognize stock-based compensation expenses over the requisite service periods. Our share-based awards are classified within equity. The amounts included in the condensed consolidated statements of operations related to stock-based compensation are as follows (dollars in thousands):



	Three Months Ended December 31,
	2018			2017
Cost of hosting and professional services	$	7,332		$	7,378
Cost of product and licensing	264			266
Cost of maintenance and support	(234		)	681
Research and development	8,830			9,007
Sales and marketing	9,257			10,164
General and administrative	8,891			8,729
Total	$	34,340		$	36,225

Stock Options

The table below summarizes activities related to stock options for the three months ended December 31, 2018:



	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value^(a)
Outstanding at September 30, 2018	19,144		$	17.31
Exercised	—		$	—
Expired	(4,528	)	$	17.89
Outstanding at December 31, 2018	14,616		$	17.13	2.9 years	$	—
Exercisable at December 31, 2018	14,616		$	17.13	2.9 years	$	—
Exercisable at December 31, 2017	21,939		$	16.41	2.8 years	$	0.1	million


^(a)	The aggregate intrinsic value in this table represents any excess of the closing market price of our common stock as of December 31, 2018 ($13.23) over the exercise price of the underlying options.

The aggregate intrinsic values of stock options exercised during the three months ended December 31, 2018 and 2017 were de minimis.

Restricted Units

Restricted units are not included in issued and outstanding common stock until the units are vested and underlying shares are released. The purchase price for vested restricted units is $0.001 per share. The table below summarizes activities relating to restricted units for the three months ended December 31, 2018:



	Number of Shares Underlying Restricted Units — Contingent Awards		Number of Shares Underlying Restricted Units — Time-Based Awards
Outstanding at September 30, 2018	3,039,568		6,872,087
Granted	1,088,105		5,679,945
Earned/released	(1,104,380	)	(4,048,965	)
Forfeited	(516,911	)	(475,729	)
Outstanding at December 31, 2018	2,506,382		8,027,338
Weighted average remaining recognition period of outstanding restricted units	2.0 years		1.9 years
Unrecognized stock-based compensation expense of outstanding restricted units	$34.5 million		$90.5 million
Aggregate intrinsic value of outstanding restricted units^(a)	$33.2 million		$106.3 million


^(a)	The aggregate intrinsic value in this table represents any excess of the closing market price of our common stock as of December 31, 2018 ($13.23) over the purchase price of the underlying restricted units.

A summary of the weighted-average grant-date fair value of restricted units granted, and the aggregate intrinsic value of restricted units vested during the periods noted is as follows:



	Three Months Ended December 31,
	2018		2017
Weighted-average grant-date fair value per share	$	16.43	$	14.92
Total intrinsic value of shares vested (in millions)	$	82.4	$	84.7